Breakthrough discovery to transform prostate cancer treatment
Monday, June 22, 2020 - 13:32
in Health & Medicine
A novel formulation of the prostate cancer drug abiraterone acetate - currently marketed as Zytiga - will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials show the new formulation improves the drug's effectiveness by 40 per cent.